0001578563-24-000182.txt : 20240325
0001578563-24-000182.hdr.sgml : 20240325
20240325173627
ACCESSION NUMBER: 0001578563-24-000182
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240321
FILED AS OF DATE: 20240325
DATE AS OF CHANGE: 20240325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Singleton Mark Leonard
CENTRAL INDEX KEY: 0001914936
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37844
FILM NUMBER: 24780324
MAIL ADDRESS:
STREET 1: C/O BIOVENTUS INC.
STREET 2: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioventus Inc.
CENTRAL INDEX KEY: 0001665988
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 810980861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 474-6700
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
wk-form4_1711402578.xml
FORM 4
X0508
4
2024-03-21
0
0001665988
Bioventus Inc.
BVS
0001914936
Singleton Mark Leonard
4721 EMPEROR BOULEVARD, SUITE 100
DURHAM
NC
27703
0
1
0
0
SVP & CFO
0
Class A Common Stock
2024-03-21
4
M
0
18625
A
31206
D
Class A Common Stock
2024-03-22
4
S
0
5541
5.3876
D
25665
D
Restricted Stock Units
2024-03-21
4
M
0
18625
0
D
Class A Common Stock
18625
37250
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2024 pursuant to a standing 10b5-1 instruction.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.36 to $5.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023.
/s/ Anthony D'Adamio, Attorney-in-Fact
2024-03-25